|
🐜
|
South African medicinal plant extracts active against influenza A virus
12 auth.
P. Mehrbod,
M. Abdalla,
E. Njoya,
A. Ahmed,
F. Fotouhi,
B. Farahmand,
...
D. Gado,
M. Tabatabaian,
O. Fasanmi,
J. Eloff,
L. Mcgaw,
F. Fasina
|
5 |
2018 |
5
🐜
|
|
🐜
|
Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus
8 auth.
F. Fotouhi,
M. Shaffifar,
B. Farahmand,
S. Shirian,
M. Saeidi,
A. Tabarraei,
...
A. Gorji,
A. Ghaemi
|
4 |
2017 |
4
🐜
|
|
🐜
|
Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran
9 auth.
Mostafa Salehi-Vaziri,
T. Jalali,
B. Farahmand,
F. Fotouhi,
M. Banifazl,
M. Pouriayevali,
...
Mona Sadat Larijani,
N. Afzali,
Amitis Ramezani
|
4 |
2021 |
4
🐜
|
|
🐜
|
Prolonged viral shedding and antibody persistence in patients with COVID-19
16 auth.
F. Fotouhi,
Mostafa Salehi-Vaziri,
B. Farahmand,
E. Mostafavi,
M. Pouriayevali,
T. Jalali,
V. Mazaheri,
M. S. Larijani,
Mahsa Tavakoli,
AzitaEshratkhah mohammadnejad,
...
N. Afzali,
Afsaneh Zokaei,
S. Hosseini,
M. M. Mortazavipour,
FaridehNiknam Oskouei,
Amitis Ramezani
|
4 |
2021 |
4
🐜
|
|
🐬
|
Effects of Protoplast Fusion on δ-endotoxin Production in Bacillus thuringiensis Spp. (H14)
Shamsi Yari,
D. N. Inanlou,
F. Yari,
M. Saleh,
B. Farahmand,
A. Akbarzadeh
|
4 |
2002 |
4
🐬
|
|
🐬
|
Molecular epidemiology of the hemagglutinin gene of prevalent influenza virus A/H1N1/pdm09 among patient in Iran.
Atefeh Mohebbi,
F. Fotouhi,
Abbas Jamali,
R. Yaghobi,
B. Farahmand,
R. Mohebbi
|
4 |
2019 |
4
🐬
|
|
🐜
|
SARS-CoV-2 re-infection rate in Iranian COVID-19 cases within one-year follow-up
18 auth.
Mostafa Salehi-Vaziri,
M. Pouriayevali,
F. Fotouhi,
T. Jalali,
M. Banifazl,
B. Farahmand,
M. S. Larijani,
Zahra Ahmadi,
Zahra Fereydouni,
Mahsa Tavakoli,
...
A. Karami,
Sanam Azad-Manjiri,
Parastoo Yektay Sanati,
S. Dahmardeh,
Amir Hesam Nemati,
Marzyie Sajadi,
Setareh Kashanian,
Amitis Ramezani
|
4 |
2021 |
4
🐜
|
